AuthorsKlempner, Mark S.
KeywordsChemicals and Drugs
Pharmaceutics and Drug Design
Pharmacy and Pharmaceutical Sciences
Translational Medical Research
MetadataShow full item record
AbstractMark Klempner, MD, Executive Vice Chancellor, MassBiologics of UMass Medical School and Professor of Medicine, describes MassBiologics and their process for developing a new medicine. MassBiologics is the only non-profit, FDA-licensed manufacturer of vaccines and biologics in the United States.
Permanent Link to this Itemhttp://hdl.handle.net/20.500.14038/50556
RightsCopyright the Author(s)